81
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Which vaccine? Between evidence-based policy and symbolic politics

&

References

  • Behague, D., Tawiah, C., Rosato, M., Some, T., & Morrison, J. (2009). Evidence-based policy-making: The implications of globally-applicable research for context-specific problem-solving in developing countries. Social Science & Medicine, 69(10), 1539–1546. https://doi.org/10.1016/j.socscimed.2009.08.006
  • Blume, S. S. (2005). Lock in, the state and vaccine development: Lessons from the history of the polio vaccines. Research Policy, 34(2), 159–173. https://doi.org/10.1016/j.respol.2004.12.001
  • Blume, S. S., & Zanders, M. (2006). Vaccine independence, local competences and globalisation: Lessons from the history of pertussis vaccines. Social Science & Medicine, 63(7), 1825–1835. https://doi.org/10.1016/j.socscimed.2006.04.014
  • Brownson, R. C., Chriqui, J. F., & Stamatakis, K. A. (2009). Understanding evidence-based public health policy. American Journal of Public Health, 99(9), 1576–1583. https://doi.org/10.2105/AJPH.2008.156224
  • Brujić, M. (2022). In Torlak we (would) trust: Domestic vaccine production in contemporary Serbia. Medical Humanities, 48(3), e11. https://doi.org/10.1136/medhum-2021-012212
  • Bryder, L. (1999). We shall not find salvation in inoculation’: BCG vaccination in Scandinavia, Britain and the USA, 1921–1960. Social Science & Medicine, 49(9), 1157–1167. https://doi.org/10.1016/S0277-9536(99)00157-4
  • Cave, E., & McMahon, A. (2022). Should states restrict recipient choice amongst relevant and available COVID-19 vaccines? Medical Law Review, 31(2), 272–292. https://doi.org/10.1093/medlaw/fwac042
  • da Fonseca, E. M., Jarman, H., King, E. J., & Greer, S. L. (2021). Perspectives in the study of the political economy of COVID-19 vaccine regulation. Regulation & Governance. Advance online publication. https://doi.org/10.1111/rego.12413
  • Dal-Ré, R., Stephens, R., & Sreeharan, N. (2021). Let me choose my COVID-19 vaccine. European Journal of Internal Medicine, 87, 104–105. https://doi.org/10.1016/j.ejim.2021.01.030
  • European Medicines Agency. (n.d.). COVID-19 vaccines: Development, evaluation, approval and monitoring. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-development-evaluation-approval-monitoring
  • Gangarosa, E. J., Galazka, A. M., Wolfe, C. R., Phillips, L. M., Gangarosa, R. E., Miller, E., & Chen, R. T. (1998). Impact of antivaccine movements on pertussis control: The untold story. The Lancet, 351(9099), 356–361. https://doi.org/10.1016/s0140-6736(97)04334-1
  • Gokmen, Y., Baskici, C., & Ercil, Y. (2021). The impact of national culture on the increase of COVID-19: A cross-country analysis of European countries. International Journal of Intercultural Relations, 81, 1–8. https://doi.org/10.1016/j.ijintrel.2020.12.006
  • Goodwin, R., Nguyen Luu, L. A., Wiwattanapantuwong, J., Kovács, M., Suttiwan, P., & Levin, Y. (2022). Two-tailed dogs, social unrest and COVID-19 vaccination: Politics, hesitancy and vaccine choice in Hungary and Thailand. Vaccines, 10(5), 789. https://doi.org/10.3390/vaccines10050789
  • Health Council of the Netherlands. (2007). De toekomst van het Rijksvaccinatieprogramma: naar een programma voor alle leeftijden. (Den Haag. Gezondheidsraad. Report No. 2007/02).
  • Higgins, A. (2021, March 17). As vaccination speeds along in Serbia, the country basks in the glow of a successful campaign. The New York Times. https://www.nytimes.com/2021/03/17/world/europe/as-vaccinations-speed-along-in-serbia-the-country-basks-in-the-glow-of-a-successful-campaign.html
  • Huzair, F., & Sturdy, S. (2017). Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968–2000. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, 64, 11–21. https://doi.org/10.1016/j.shpsc.2017.05.004
  • Jauregui, B., Garcia, A. G., Bess Janusz, C., Blau, J., Munier, A., Atherly, D., Mvundura, M., Hajjeh, R., Lopman, B., Clark, A. D., Baxter, L., Hutubessy, R., de Quadros, C., & Andrus, J. K. (2015). Evidence-based decision-making for vaccine introductions: Overview of the ProVac international working group’s experience. Vaccine: X, 33(1), A28–A33. https://doi.org/10.1016/j.vaccine.2014.10.090
  • Kawata, K., & Nakabayashi, M. (2021). Determinants of COVID-19 vaccine preference: A survey study in Japan. SSM - Population Health, 15, 100902. https://doi.org/10.1016/j.ssmph.2021.100902
  • Kazharski, A., & Makarychev, A. (2021). Russia’s vaccine diplomacy in Central Europe: Between a political campaign and a business project. Czech Journal of International Relations, 56(4), 131–146. https://doi.org/10.32422/cjir.35
  • Kramer, D. B., Opel, D. J., Parasidis, E., & Mello, M. M. (2021). Choices in a crisis - Individual preferences among SARS-CoV-2 vaccines. The New England Journal of Medicine, 384(17), e62. https://doi.org/10.1056/NEJMp2102146
  • Kutasi, K., Koltai, J., Szabó-Morvai, Á., Röst, G., Karsai, M., Biró, P., & Lengyel, B. (2022). Understanding hesitancy with revealed preferences across COVID-19 vaccine types. Scientific Reports, 12(1), 13293. https://doi.org/10.1038/s41598-022-15633-5
  • Madhavi, Y. (2003). Manufacture of consent? Hepatitis B vaccination. Economic and Political Weekly, 38(24), 2417–2424.
  • Marelli, L., Kieslich, K., & Geiger, S. (2022). COVID-19 and techno-solutionism: Responsibilization without contextualization? Critical Public Health, 32(1), 1–4. https://doi.org/10.1080/09581596.2022.2029192
  • Milstien, J., Batson, A., & Meaney, W. (1997). A systematic method for evaluating the potential viability of local vaccine producers. Vaccine: X, 15(12–13), 1358–1363. https://doi.org/10.1016/s0264-410x(97)00053-4
  • Rapaka, R. R., Hammershaimb, E. A., & Neuzil, K. M. (2022). Are some COVID-19 vaccines better than others? Interpreting and comparing estimates of efficacy in vaccine trials. Clinical Infectious Diseases, 74(2), 352–358. https://doi.org/10.1093/cid/ciab213
  • Sprengholz, P., Eitze, S., Korn, L., Siegers, R., & Betsch, C. (2021). The power of choice: Experimental evidence that freedom to choose a vaccine against COVID-19 improves willingness to be vaccinated. European Journal of Internal Medicine, 87, 106–108. https://doi.org/10.1016/j.ejim.2021.03.015
  • Trifunović, V. (2022). Vaccine hesitancy in Western and Eastern Europe: The significance of contextual influences. Bulletin of the Institute of Ethnography SASA, 60(3), 153–173. https://doi.org/10.2298/GEI2203153T
  • Trifunović, V., Bach Habersaat, K., Tepavčević, D. K., Jovanović, V., Kanazir, M., Lončarević, G., & Jackson, C. (2022). Understanding vaccination communication between health workers and parents: A tailoring immunization programmes (TIP) qualitative study in Serbia. Human Vaccines & Immunotherapeutics, 18(1), 1913962. https://doi.org/10.1080/21645515.2021.1913962
  • Vargha, D. (2014). Between east and west. Polio vaccination across the iron curtain in Cold War Hungary. Bulletin of the History of Medicine, 88(2), 319–342. https://doi.org/10.1353/bhm.2014.0040
  • Vlassov, V. (2021, May 6). Sputnik V and Russia’s COVID-19 vaccine race. The BMJ Opinion. https://blogs.bmj.com/bmj/2021/05/06/vasiliy-vlassov-sputnik-v-and-russias-covid-19-vaccine-race/
  • World Health Organization. (n.d.). Vaccines granted emergency use listing (EUL) by WHO. https://covid19.trackvaccines.org/agency/who/

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.